Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Accepts Indian Inspectors To Check Quality Of Bulk Drugs

This article was originally published in PharmAsia News

Executive Summary

China and India are launching a cooperative drug inspection effort that kicks off with India's Ministry of Health sending a team to China to inspect bulk drugs. India relies on China-produced bulk drugs for much of its drug production, but the Drug Controller General of India recently questioned the quality of those supplies. China is the source of 70 percent of bulk drugs imported by India. An industry official suggested the emphasis has been too much on the cheaper price of imported drugs and not enough on their quality. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072687

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel